Mother to Child Transmission of Hepatitis B: Examining Viral Cut Offs, Maternal HBsAg Serology and Infant Testing
ConclusionAntiviral therapy initiated at 32 weeks when maternal viral load is ≥6 log10IU/mL almost completely abrogates transmission. Quantitative HBsAg does not reliably predict high viral load. When maternal viral load is <6 log10IU/mL, high vaccine efficacy and zero transmission suggests testing infants is of little value.This article is protected by copyright. All rights reserved.
Source: Liver International - Category: Gastroenterology Authors: Cynthuja Thilakanathan, Gabrielle Wark, Michael Maley, Scott Davison, Joseph Lawler, Aimei Lee, Nicholas Shackel, Vi Nguyen, Kathy Jackson, Anne Glass, Stephen A Locarnini, Miriam T Levy Tags: Original Article Source Type: research
More News: Antiviral Therapy | Babies | Children | Gastroenterology | Hepatitis | Hepatitis B | Hepatitis Vaccine | Legislation | Liver | Study | Urology & Nephrology | Vaccines | Viread | Women